Clifford Sosin - CAS Investment Partners
As of Q2 2026, Clifford Sosin reported 6 long-equity positions worth $1.88B in aggregate.
Copy-investor backtest
- Latest quarter
- +11.59%
- 1-year
- +8.26%
- 3-year
- +282.39%
- 5-year
- +18.74%
- 3-year vs S&P 500
- +209.15%
- 5-year vs S&P 500
- -55.35%
- 5-year top 5
- +18.74%
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when Clifford Sosin files a new 13F — sign in or create a free account.
Updated 2026-06-06 from SEC 13F data.
Live quotes available for 4 of 5 rows. Rows without a quote are marked unavailable.
| 1 | CVNA | CARVANA CO | 40.66% | Add +0.4% | 2,535,331 | $158.69M | $62.59 | No quote |
| 2 | WRLD | WORLD ACCEP CORP DEL | 24.45% | Reduce -14.2% | 581,479 | $95.43M | No quote | No quote |
| 3 | CDLX | CARDLYTICS INC | 14.39% | New | 2,162,020 | $56.17M | $25.98 | No quote |
| 4 | HLF | HERBALIFE NUTRITION LTD | 12.39% | - | 1,130,482 | $48.34M | $42.76 | No quote |
| 5 | CACC | CREDIT ACCEP CORP MICH | 8.12% | Reduce -39.4% | 65,468 | $31.68M | $483.82 | No quote |